MedTrace Logo

Depression Screening in Patients Undergoing Radiation Therapy For Cancer

NCT00951184 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 463

Last updated 2015-03-18

No results posted yet for this study

Summary

RATIONALE: Gathering information about depression in patients with cancer may help doctors learn more about the disease and plan the best treatment.

PURPOSE: This clinical trial is studying depression screening in patients undergoing radiation therapy for cancer.

Conditions

  • Depression
  • Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BEHAVIORAL

telephone-based intervention

OTHER

screening questionnaire administration

OTHER

study of socioeconomic and demographic variables

PROCEDURE

assessment of therapy complications

PROCEDURE

psychosocial assessment and care

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • NRG Oncology

    collaborator OTHER

  • Radiation Therapy Oncology Group

    lead NETWORK

Principal Investigators

  • Lynne Wagner, MD · Robert H. Lurie Cancer Center

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2011-10-31
Completion
2014-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00951184 on ClinicalTrials.gov